CPHI Webinar Series

Unlocking Opportunities in the Growing Pharma Landscape of The Middle East

5th June, 2024
15:00 CET / 9:00 EST
What will this webinar address?

CPHI Middle East, set to launch in Riyadh, Saudi Arabia from December 10-12, 2024, is a brand-new event for the region, offering a unique platform designed to foster cross-industry collaboration and to catalyze growth. The Middle East is the fifth largest pharma market globally, valued at USD 20 Billion, led by Saudi Arabia with a 37% market share.

A market poised for maturity; the Kingdom of Saudi has outlined an ambitious plan to revolutionize the life sciences industry - Vision 2030. The plan seeks to reduce reliance on imported medicines by building out a dynamic infrastructure of regional manufacturing facilities for both small and large molecule production.

This webinar will bring together key stakeholders to discuss the future of the Middle East pharma market. Discussion points include:


  • Building out an eco-system to support localised manufacturing through partnerships, investment and tech-transfer
  • How technology advancements from CPO’s can help accelerate production, reduce costs and mitigate risk.
  • Establishing the region as an innovator market, how to incentivize and enable R&D to create a pipeline of home-grown innovative therapies.
  • Identifying the opportunities for international pharma companies – why the Middle East presents a big opportunity for Big Pharma
Lucy Chard
Digital Editor, Pharma
Informa Markets

Overview
Unlocking Opportunities in the Growing Pharma Landscape of The Middle East
  • 5th June, 2024
  • 15:00 CET / 9:00 EST
  • 60 minutes
  • Free
CPHI Newsletter

Get the latest from CPHI in your inbox every week.

You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time by clicking on the Unsubscribe link in the Newsletters or opting out on our unsubscribe page page.